According to the World Health Organization, of the roughly 10 million people who fall ill with TB annually, over 80% survive, in most cases due to a six-month treatment course. Unfortunately, as with long COVID, being cured is not always the last hurdle and many people go on to struggle with post-TB lung disease. Tiyese Jeranji asked local experts about this sometimes-neglected area of TB care.
There is still no test to diagnose long-COVID and also no cure. It’s the fallout of the pandemic that is fast becoming a mounting health concern. Ufrieda Ho reports.
Professor Resia Pretorius and her colleagues at the University of Stellenbosch are at the cutting edge of research into one of the most likely causes of long COVID – inflammatory microclots. Adele Baleta spoke to Pretorius about their work.
The first long COVID study conducted in South Africa found that 82% of patients still had persistent or new symptoms a month after their discharge from hospital. However, much is still unknown about what exactly causes this and how to alleviate the suffering, which is becoming an increasing health burden across the globe. Elsabé Brits surveyed the latest evidence and asked local experts to place it in context.
As a third wave of COVID-19 looms in the Western Cape, a group of doctors at Groote Schuur Hospital’s Post-COVID-19 Lung Disease Clinic are treating patients who have recovered from COVID-19 but who suffer lingering symptoms such as fatigue and shortness of breath. Bienne Huisman paid them a visit.
A study published in the Lancet medical journal confirms that the health effects of COVID-19 can linger months after someone has ‘recovered’. Kathryn Cleary asked local experts about the underlying science and whether the South African public healthcare system is ready for so-called long-COVID.
